Why not price caps?

Why are price caps a bad solution for medicine affordability? Americans need affordable access to medicines, but upper payment limits (UPLs) set by prescription drug affordability boards and Medicare Maximum Fair Prices (MFPs) are not viable solutions. In our complex drug supply chain, these price caps could bankrupt pharmacies and reduce patient access. Read our…

[...]

Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety

front page of pdf about unsafe GLPs at medspas

Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.

[...]

Threats to HIV patients from criminals in the drug supply chain

Since 2019, federal prosecutors, drug manufacturers, and patient safety organizations have uncovered extensive criminal schemes targeting HIV medicines at every point in the supply chain. These schemes undermine trust in the healthcare system, and they endanger patients.

[...]

Prescription Drug Freight Fraud Report, September 2025

Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.

[...]

Handout: The fake pill trade hasn’t gone away

Handout: The fake pill trade hasn’t gone away It’s been 10 years since deadly counterfeit prescription pills began killing Americans. News about fake pill deaths has become commonplace and advocates have made progress to protect lives, but many people still don’t know about this threat or the pill presses that make it possible. Share this…

[...]